Atgen Co. Ltd. | Mutual Funds
Mutual Funds that own Atgen Co. Ltd.
iShares Core MSCI Emerging Markets ETF
335,006
1.36%
0
0.01%
09/05/2018
277,775
1.12%
0
1.02%
09/06/2018
Vanguard Total International Stock Index Fund
249,320
1.01%
0
0%
07/31/2018
144,448
0.59%
0
3.54%
12/28/2017
Vanguard Developed Markets Index Fund
105,163
0.43%
0
0%
07/31/2018
Government Pension Fund - Global (The)
69,632
0.28%
10,880
0%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
45,292
0.18%
0
0.01%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
43,265
0.18%
0
0.01%
09/05/2018
Mirae Asset TIGER Health Care ETF
40,118
0.16%
10,532
0.39%
04/30/2018
Vanguard Pacific Stock Index Fund
23,030
0.09%
0
0%
07/31/2018
| Address |
1st & 6th Floor, Health Care Park
Seongnam-si GY 13605
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.nkvue.com |
| Updated |
09/14/2018 |
| ATGen Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. Its products include NK cells under NK Vue brand, recombinant proteins, and monoclonal antibodies. The company was founded on January 14, 2002 and is headquartered at Seongnam-si, South Korea. |
